Literature DB >> 26629443

Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?

Robert J Cerfolio1, James H Estes1.   

Abstract

Year:  2015        PMID： 26629443      PMCID： PMC4630517          DOI： 10.3978/j.issn.2218-6751.2015.07.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  2 in total

1.  Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.

Authors:  Cliff G Robinson; Aalok P Patel; Jeffrey D Bradley; Todd DeWees; Saiama N Waqar; Daniel Morgensztern; Maria Q Baggstrom; Ramaswamy Govindan; Jennifer M Bell; Tracey J Guthrie; Graham A Colditz; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

2.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Authors:  Brian E Lally; Daniel Zelterman; Joseph M Colasanto; Bruce G Haffty; Frank C Detterbeck; Lynn D Wilson
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544
  2 in total
  1 in total

1.  Response to "Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?".

Authors:  Cliff G Robinson; Aalok P Patel; Todd DeWees; Daniel Morgensztern; Jeffrey D Bradley; Varun Puri
Journal:  Transl Lung Cancer Res       Date:  2015-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.